GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AddLife AB (OSTO:ALIF B) » Definitions » Cyclically Adjusted PS Ratio

AddLife AB (OSTO:ALIF B) Cyclically Adjusted PS Ratio : 2.27 (As of Jun. 05, 2024)


View and export this data going back to 2016. Start your Free Trial

What is AddLife AB Cyclically Adjusted PS Ratio?

As of today (2024-06-05), AddLife AB's current share price is kr113.00. AddLife AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was kr49.76. AddLife AB's Cyclically Adjusted PS Ratio for today is 2.27.

The historical rank and industry rank for AddLife AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

OSTO:ALIF B' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.97   Med: 2.15   Max: 2.32
Current: 2.3

During the past years, AddLife AB's highest Cyclically Adjusted PS Ratio was 2.32. The lowest was 1.97. And the median was 2.15.

OSTO:ALIF B's Cyclically Adjusted PS Ratio is ranked worse than
51.57% of 477 companies
in the Medical Devices & Instruments industry
Industry Median: 2.15 vs OSTO:ALIF B: 2.30

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

AddLife AB's adjusted revenue per share data for the three months ended in Mar. 2024 was kr21.090. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr49.76 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AddLife AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for AddLife AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AddLife AB Cyclically Adjusted PS Ratio Chart

AddLife AB Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AddLife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 2.25

Competitive Comparison of AddLife AB's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, AddLife AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AddLife AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AddLife AB's Cyclically Adjusted PS Ratio falls into.



AddLife AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

AddLife AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=113.00/49.76
=2.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AddLife AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, AddLife AB's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=21.09/132.2054*132.2054
=21.090

Current CPI (Mar. 2024) = 132.2054.

AddLife AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201303 0.000 100.416 0.000
201403 0.000 99.788 0.000
201412 3.310 100.225 4.366
201503 3.122 99.950 4.130
201506 3.999 99.995 5.287
201509 4.477 100.228 5.905
201512 5.704 100.276 7.520
201603 4.991 100.751 6.549
201606 4.791 101.019 6.270
201609 3.958 101.138 5.174
201612 5.967 102.022 7.732
201703 5.620 102.022 7.283
201706 5.581 102.752 7.181
201709 5.054 103.279 6.470
201712 6.545 103.793 8.337
201803 5.880 103.962 7.477
201806 6.127 104.875 7.724
201809 5.725 105.679 7.162
201812 6.951 105.912 8.677
201903 7.920 105.886 9.889
201906 7.477 106.742 9.261
201909 7.132 107.214 8.794
201912 8.805 107.766 10.802
202003 9.351 106.563 11.601
202006 11.117 107.498 13.672
202009 11.058 107.635 13.582
202012 15.083 108.296 18.413
202103 15.363 108.360 18.744
202106 18.774 108.928 22.786
202109 15.171 110.338 18.178
202112 17.193 112.486 20.207
202203 21.174 114.825 24.379
202206 17.082 118.384 19.076
202209 17.150 122.296 18.540
202212 18.658 126.365 19.520
202303 20.051 127.042 20.866
202306 19.408 129.407 19.828
202309 19.031 130.224 19.321
202312 20.874 131.912 20.920
202403 21.090 132.205 21.090

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AddLife AB  (OSTO:ALIF B) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


AddLife AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of AddLife AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AddLife AB (OSTO:ALIF B) Business Description

Traded in Other Exchanges
Address
Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.

AddLife AB (OSTO:ALIF B) Headlines

No Headlines